| Primary |
| Rheumatoid Arthritis |
35.3% |
| Colitis Ulcerative |
17.5% |
| Psoriatic Arthropathy |
6.8% |
| Ankylosing Spondylitis |
4.6% |
| Arthritis |
4.4% |
| Crohn's Disease |
4.0% |
| Ill-defined Disorder |
3.5% |
| Hypertension |
3.3% |
| Drug Use For Unknown Indication |
2.7% |
| Arthralgia |
2.5% |
| Pain |
2.2% |
| Colitis |
2.0% |
| Polyarthritis |
1.9% |
| Arthritis Reactive |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Musculoskeletal Pain |
1.3% |
| Juvenile Arthritis |
1.1% |
| Depression |
1.0% |
| Hypothyroidism |
1.0% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
13.9% |
| Rash |
10.2% |
| Pyrexia |
8.4% |
| Drug Hypersensitivity |
6.5% |
| Drug Ineffective |
5.6% |
| Neutropenia |
5.6% |
| Vomiting |
4.6% |
| White Blood Cell Count Decreased |
4.3% |
| Sepsis |
4.0% |
| Weight Decreased |
4.0% |
| Headache |
3.7% |
| Pancytopenia |
3.7% |
| Stevens-johnson Syndrome |
3.7% |
| Liver Disorder |
3.4% |
| Nausea |
3.1% |
| Neutropenic Sepsis |
3.1% |
| Rash Maculo-papular |
3.1% |
| Swelling Face |
3.1% |
| Toxic Epidermal Necrolysis |
3.1% |
| Drug Eruption |
2.8% |
|
| Secondary |
| Rheumatoid Arthritis |
31.4% |
| Product Used For Unknown Indication |
23.6% |
| Ankylosing Spondylitis |
5.8% |
| Drug Use For Unknown Indication |
5.7% |
| Colitis Ulcerative |
4.5% |
| Arthritis |
3.5% |
| Psoriatic Arthropathy |
3.5% |
| Crohn's Disease |
3.0% |
| Hypertension |
2.4% |
| Oedema Peripheral |
2.4% |
| Joint Swelling |
2.2% |
| Spondylitis |
2.1% |
| Polyarthritis |
1.5% |
| Osteoarthritis |
1.4% |
| Pulmonary Tuberculosis |
1.4% |
| Pain |
1.3% |
| Upper Respiratory Tract Infection |
1.2% |
| Juvenile Arthritis |
1.1% |
| Inflammatory Bowel Disease |
1.0% |
| Depression |
1.0% |
|
| Weight Decreased |
9.3% |
| Toxic Epidermal Necrolysis |
8.1% |
| Vomiting |
8.1% |
| Drug Hypersensitivity |
7.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.9% |
| Hepatitis B |
5.2% |
| Gastritis |
4.8% |
| Renal Failure Acute |
4.8% |
| Drug Ineffective |
4.4% |
| Pyrexia |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Cardiomegaly |
4.0% |
| White Blood Cell Count Increased |
4.0% |
| Liver Function Test Abnormal |
3.6% |
| Liver Injury |
3.6% |
| Rash |
3.6% |
| Dermatitis Exfoliative |
3.2% |
| Intestinal Perforation |
3.2% |
| Oedema Peripheral |
3.2% |
| Pneumonia |
3.2% |
|
| Concomitant |
| Rheumatoid Arthritis |
31.1% |
| Product Used For Unknown Indication |
21.2% |
| Drug Use For Unknown Indication |
18.4% |
| Crohn's Disease |
5.5% |
| Ankylosing Spondylitis |
4.0% |
| Hypertension |
3.0% |
| Psoriatic Arthropathy |
3.0% |
| Pain |
2.2% |
| Colitis Ulcerative |
1.8% |
| Osteoporosis |
1.3% |
| Arthritis |
1.2% |
| Vitamin Supplementation |
1.1% |
| Depression |
1.0% |
| Prophylaxis |
1.0% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Psoriasis |
0.7% |
| Diabetes Mellitus |
0.7% |
| Asthma |
0.7% |
| Premedication |
0.6% |
| Insomnia |
0.6% |
|
| Injection Site Pain |
13.6% |
| Rheumatoid Arthritis |
10.2% |
| Vomiting |
8.2% |
| Weight Decreased |
6.1% |
| Pneumonia |
6.0% |
| Pain In Extremity |
5.0% |
| Pain |
4.9% |
| Pyrexia |
4.5% |
| Urinary Tract Infection |
4.5% |
| Drug Ineffective |
4.4% |
| Rash |
3.9% |
| Arthralgia |
3.7% |
| Nausea |
3.5% |
| Sinusitis |
3.5% |
| Nasopharyngitis |
3.3% |
| Sepsis |
3.1% |
| Injection Site Swelling |
2.9% |
| Headache |
2.9% |
| Death |
2.8% |
| Weight Increased |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
46.0% |
| Drug Use For Unknown Indication |
17.0% |
| Rheumatoid Arthritis |
14.0% |
| Colitis Ulcerative |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Psoriatic Arthropathy |
3.0% |
| Anticoagulant Therapy |
2.0% |
| Contraception |
2.0% |
| Diabetes Mellitus Insulin-dependent |
2.0% |
| Inflammatory Bowel Disease |
2.0% |
| Osteoporosis |
2.0% |
| Polyarthritis |
2.0% |
| Analgesic Therapy |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
|
| Drug Interaction |
15.0% |
| Headache |
15.0% |
| Red Blood Cell Count Decreased |
15.0% |
| International Normalised Ratio Increased |
10.0% |
| Somnolence |
10.0% |
| Agranulocytosis |
5.0% |
| Drug Level Decreased |
5.0% |
| Hepatitis |
5.0% |
| Pleural Infection |
5.0% |
| Renal Failure Acute |
5.0% |
| Sensory Disturbance |
5.0% |
| Suicidal Ideation |
5.0% |
|
